Southeast BIO Recognizes Argos Therapeutics with the “2012 Southeast BIO Deal of the Year: Venture Capital Transaction” Award

Argos Therapeutics Inc., a biopharmaceutical company focused on the development and commercialization of fully personalized immunotherapies for the treatment of cancer and infectious diseases using its Arcelis™ technology platform, was presented with the “... [more]

View complete Press Release article